Alternatives to TrialJectory

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

AI-powered platform personalizing and optimizing cancer patient monitoring and treatment.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.